BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19004540)

  • 1. Podocalyxin selectively marks erythroid-committed progenitors during anemic stress but is dispensable for efficient recovery.
    Maltby S; Hughes MR; Zbytnuik L; Paulson RF; McNagny KM
    Exp Hematol; 2009 Jan; 37(1):10-8. PubMed ID: 19004540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sox6 is necessary for efficient erythropoiesis in adult mice under physiological and anemia-induced stress conditions.
    Dumitriu B; Bhattaram P; Dy P; Huang Y; Quayum N; Jensen J; Lefebvre V
    PLoS One; 2010 Aug; 5(8):e12088. PubMed ID: 20711497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolysis-driven IFNα production impairs erythropoiesis by negatively regulating EPO signaling in sickle cell disease.
    Han Y; Gao C; Liu Y; Zhang H; Wang S; Zhao H; Bao W; Guo X; Vinchi F; Lobo C; Shi P; Mendelson A; Luchsinger L; Zhong H; Yazdanbakhsh K; An X
    Blood; 2024 Mar; 143(11):1018-1031. PubMed ID: 38127913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tropomodulin3-null mice are embryonic lethal with anemia due to impaired erythroid terminal differentiation in the fetal liver.
    Sui Z; Nowak RB; Bacconi A; Kim NE; Liu H; Li J; Wickrema A; An XL; Fowler VM
    Blood; 2014 Jan; 123(5):758-67. PubMed ID: 24159174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMP4/Smad5 dependent stress erythropoiesis is required for the expansion of erythroid progenitors during fetal development.
    Porayette P; Paulson RF
    Dev Biol; 2008 May; 317(1):24-35. PubMed ID: 18374325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of two routinely used protocols for ex vivo erythroid differentiation.
    Godard A; Seute R; Grimaldi A; Granier T; Chiaroni J; El Nemer W; De Grandis M
    Blood Cells Mol Dis; 2024 May; 106():102829. PubMed ID: 38278056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordination of erythropoiesis by the transcription factor c-Myb.
    Vegiopoulos A; García P; Emambokus N; Frampton J
    Blood; 2006 Jun; 107(12):4703-10. PubMed ID: 16484593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering the regulatory landscape of murine splenic response to anemic stress at single-cell resolution.
    Yang C; Yokomori R; Chua LH; Tan SH; Koh MY; Totani H; Sanda T; Suda T
    Blood Adv; 2024 Apr; 8(7):1651-1666. PubMed ID: 38315834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation by CD47 and thrombospondin-1 of extramedullary erythropoiesis in mouse spleen.
    Banerjee R; Meyer TJ; Cam MC; Kaur S; Roberts DD
    bioRxiv; 2024 Apr; ():. PubMed ID: 37808833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Key Regulators of Steady-State and Ineffective Erythropoiesis.
    Țichil I; Mitre I; Zdrenghea MT; Bojan AS; Tomuleasa CI; Cenariu D
    J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ISG15 modulates development of the erythroid lineage.
    Maragno AL; Pironin M; Alcalde H; Cong X; Knobeloch KP; Tangy F; Zhang DE; Ghysdael J; Quang CT
    PLoS One; 2011; 6(10):e26068. PubMed ID: 22022510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Steady-State Erythropoiesis in Different Mouse Bones and Postnatal Spleen.
    Myneni VD; Szalayova I; Mezey E
    Front Cell Dev Biol; 2021; 9():646646. PubMed ID: 34055777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p53 tumour suppressor inhibits glucocorticoid-induced proliferation of erythroid progenitors.
    Ganguli G; Back J; Sengupta S; Wasylyk B
    EMBO Rep; 2002 Jun; 3(6):569-74. PubMed ID: 12034755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoblastic erythropoietin is not required for bone mass accrual.
    Lanzolla G; Merceron C; Khan MP; Sabini E; Giaccia A; Schipani E
    JBMR Plus; 2024 Jun; 8(6):ziae052. PubMed ID: 38764792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ancient genomic linkage couples metabolism with erythroid development.
    Preston AE; Frost JN; Badat M; Teh M; Armitage AE; Norfo R; Wideman SK; Hanifi M; White N; Roy N; Ghesquiere B; Babbs C; Kassouf M; Davies J; Hughes JR; Beagrie R; Higgs DR; Drakesmith H
    bioRxiv; 2023 Sep; ():. PubMed ID: 37808769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocalyxin in Normal Tissue and Epithelial Cancer.
    Le Tran N; Wang Y; Nie G
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34201212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Toxicity Study of Engineered Lipid Microbubbles in Rodents.
    Paradossi G; Oddo L; Cerroni B; Ben-Harush C; Ariel E; Di Meco F; Ram Z; Grossman R
    ACS Omega; 2019 Mar; 4(3):5526-5533. PubMed ID: 31497678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocalyxin is required for maintaining blood-brain barrier function during acute inflammation.
    Cait J; Hughes MR; Zeglinski MR; Chan AW; Osterhof S; Scott RW; Canals Hernaez D; Cait A; Vogl AW; Bernatchez P; Underhill TM; Granville DJ; Murphy TH; Roskelley CD; McNagny KM
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4518-4527. PubMed ID: 30787191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocalyxin regulates murine lung vascular permeability by altering endothelial cell adhesion.
    Debruin EJ; Hughes MR; Sina C; Lu A; Cait J; Jian Z; Lopez M; Lo B; Abraham T; McNagny KM
    PLoS One; 2014; 9(10):e108881. PubMed ID: 25303643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A familiar stranger: CD34 expression and putative functions in SVF cells of adipose tissue.
    Scherberich A; Di Maggio ND; McNagny KM
    World J Stem Cells; 2013 Jan; 5(1):1-8. PubMed ID: 23362435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.